Are Toll-like receptor gene polymorphisms associated with prostate cancer?

Cancer Management and Research

Volumn 4, Issue 1, 2012, Pages 23-29

  Kutikhin, Anton G ^a   Yuzhalin, Arseniy E ^a  

^a KEMEROVO STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Genetic variation; Inflammation; Innate immunity; Single nucleotide polymorphisms; TLRs

Indexed keywords

DNA; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; TOLL LIKE RECEPTOR;

CANCER GRADING; CANCER RISK; CANCER STAGING; DNA POLYMORPHISM; GENETIC CODE; HUMAN; METASTASIS; MORTALITY; NOTE; PATHOGENESIS; PROSTATE CANCER; RELIABILITY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84857085169     PISSN: None     EISSN: 11791322     Source Type: Journal    
DOI: None     Document Type: Note

References (15)

1. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol. 1999;155(6):1985-1992.
2. Zheng SL, Augustsson-Bälter K, Chang B, et al. Sequence variants of Toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res. 2004;64(8):2918-2922.
3. Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res. 2005;65(24):11771-11778.
4. Sun J, Wiklund F, Zheng SL, et al. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Natl Cancer Inst. 2005;97(7):525-532.
5. Yeager M, Orr N, Hayes RB, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet. 2007;39(5):645-649.
6. Chen YC, Giovannucci E, Kraft P, Lazarus R, Hunter DJ. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(10):1982-1989.
7. Lindström S, Hunter DJ, Grönberg H, et al. Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk: results based on pooled analysis from three independent studies. Cancer Epidemiol Biomarkers Prev. 2010;19(3):873-876.
8. Stevens VL, Hsing AW, Talbot JT, et al. Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. Int J Cancer 2008;123(11):2644-2650.
9. Balistreri CR, Caruso C, Carruba G, et al. A pilot study on prostate cancer risk and pro-inflammatory genotypes: pathophysiology and therapeutic implications. Curr Pharm Des. 2010;16(6):718-724.
10. Cheng I, Plummer SJ, Casey G, Witte JS. Toll-like receptor 4 genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16(2):352-355.
11. Song J, Kim DY, Kim CS, et al. The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men. Cancer Genet Cytogenet. 2009;190(2):88-92.
12. Wang MH, Helzlsouer KJ, Smith MW, et al. Association of IL10 and other immune response-and obesity-related genes with prostate cancer in CLUE II. Prostate. 2009;69(8):874-885.
13. Kim HJ, Bae JS, Chang IH, et al. Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men. World J Urol. Epub 2011 May 7.
14. Shui IM, Stark JR, Penney KL, et al. Genetic variation in the Toll-like receptor 4 and prostate cancer incidence and mortality. Prostate. Epub 2011 May 11.
15. Sun J, Wiklund F, Hsu FC, et al. Interactions of sequence variants in interleukin-1 receptor-associated kinase 4 and the Toll-like receptor 6-1-10 gene cluster increase prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15(3):480-485.